October WTI crude oil (CLV26) closed up +6.43 (+6.69%) on Thursday, and October RBOB gasoline (RBV26) closed up +0.1826 (+5.69%).
Crude oil and gasoline prices surged on Thursday, with crude oil posting a 3.5-month high and gasoline posting a 2-week high. Crude prices are rallying sharply amid fears that the US-Iran war will persist, reducing Middle East energy exports and tightening global oil supplies. Crude prices rallied on Thursday despite a bearish weekly EIA inventory report.
Crude Oil Prices Soar on Fears US-Iran War to Persist
What are Markets Waiting on Thursday Morning?
Nat-Gas Prices Recover as European Nat-Gas Surges

#october #fears #closed

Nucor Corporation (NUE) is the largest steel producer and recycler in the U.S., with operations spanning steel mills, steel products, and raw materials. Headquartered in Charlotte, North Carolina, the company produces a broad range of steel, from sheet and structural steel to joists, girders, and tubing, serving critical end markets such as construction, infrastructure, manufacturing, and energy.
With a market capitalization of $58.2 billion, NUE firmly sits in the large-cap category, reflecting its scale, industry influence, and leadership within the U.S. steel sector. Unlike traditional blast-furnace producers, Nucor primarily uses scrap-based electric arc furnaces (EAFs), giving it greater production flexibility and a comparatively lower environmental footprint.
'Not Tens Of Billions, But Tens Of Trillions': Nvidia CEO Jensen Huang Says AI Is Like the New Electricity and the Scale Is Unlike Any Tech in History
What It Means for MSFT Stock Investors as Microsoft Switches to 2 Business Segments
RKLB Stock Jumps as Rocket Lab Debuts New Solar Cell for **** e

#steel #north

Interested in AbbVie Inc.? Here are five stocks we like better.
SKYRIZI and RINVOQ remain AbbVie's main growth drivers, with additional opportunities in inflammatory bowel disease, vitiligo, alopecia and hidradenitis suppurativa. The company expects a subcutaneous SKYRIZI induction approval for Crohn's disease in the fourth quarter and plans further combination-therapy data.
AbbVie is advancing a broad pipeline, including the BCMA-directed cancer therapy etentamig, which showed strong early multiple-myeloma results and could support a rapid regulatory filing. Neuroscience programs such as bretisilocin for depression are also expected to deliver additional data this year.
The company is taking a selective approach to acquisitions and partnerships, having invested about $20 billion in roughly 30 transactions while increasing annual R&D spending toward $10 billion. Management maintained its outlook for high-single-digit annual revenue growth through the decade.
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It

#disease #company #Therapy

GFL Environmental Inc. (NYSE:GFL) completed its acquisition of SECURE Waste Infrastructure, adding a specialized waste and energy-infrastructure platform across Western Canada and North Dakota. At the announcement, the transaction had a C$6.4 billion enterprise value, with shareholder consideration comprising 80% GFL shares and 20% cash.
Closing required the issuance of 75,126,306 subordinate voting shares, capacity under the revolving credit facility, and a new US$1 billion senior secured term loan. The loan matures in August 2033 and carries interest at the Secured Overnight Financing Rate plus 200 basis points. GFL Environmental Inc. (NYSE:GFL) estimates an interest rate of approximately 5% after its cross-currency interest-rate swaps.
SECURE brings a difficult-to-replicate network spanning more than 80 locations, including landfills, waste-treatment and recycling facilities, injection wells and transfer stations. It also operates crude oil terminals, storage facilities and pipeline-connected infrastructure. The ****** ets broaden services and operating density in Western Canada.
More than 2,000 SECURE employees are joining the combined company. SECURE President and Chief Executive Officer Allen Gransch and other managers will continue leading the acquired operations as employees and shareholders. Retaining the operating team should help preserve customer relationships and institutional knowledge during integration.
The acquisition cost is spread across debt and equity. The 2033 maturity provides time for cash generation, while management said the term-loan transaction did not affect the company's credit rating.

#secure

Impax ***** et Management, based in London and specializing in sustainable investing, released its Q2 2026 investor letter for the "Impax US Sustainable Economy Fund". The letter can be downloaded here. The US Sustainable Economy portfolio outperformed the Russell 1000 in Q2 2026, with Institutional Class at 17.96%, Investor Class at 17.95%, and Class A at 17.92%, versus the index's 15.14%. Sector allocation and stock selection drove performance. The sustainability tools, including the Impax Sustainability Lens and Corporate Resilience framework, contributed positively. Equity markets rallied, with both the S&P 500 and Nasdaq reaching new highs before retreating. A key trend was rotation into AI and tech stocks, supported by mega-cap earnings and data center investments (US$750bn to US$1tn). In the second half of 2026, markets may remain volatile amid debates on AI adoption pace and economic momentum. However, growth tied to energy security and efficiency remains compelling, with demand for power, grid, and resource-efficient solutions supporting companies that benefit. The team focuses on businesses with strong growth, sound management, and attractive valuations, adjusting holdings as needed. This approach aims to build well-diversified, differentiated portfolios. Also, please check the fund's top five holdings for its best picks in 2026.
In its second-quarter 2026 investor letter, Impax US Sustainable Economy Fund highlighted Verizon Communications Inc. (NYSE:VZ). Verizon Communications Inc. (NYSE:VZ) is a leading telecommunication company that engages in the provision of communications, technology, information, and streaming products and services. On September 04, 2026, Verizon Communications Inc. (NYSE:VZ) closed at $50.14 per share. Over the past month, Verizon Communications Inc. (NYSE:VZ) returned 6.61%, but its shares are up 15.74% over the past year. Verizon Communications Inc. (NYSE:VZ) has a market capitalization of $208.32 billion, and its stock has traded within a 52-week range of $38.39 to $51.68.
Impax US Sustainable Economy Fund stated the following regarding Verizon Communications Inc. (NYSE:VZ) in its Q2 2026 investor letter:
"Verizon Communications Inc. (NYSE:VZ) (Wireless Telecommunication Services, Communication Services) is held for its high Corporate Resilience score and its sustainability opportunity exposure in areas including Digital Infrastructure and Meeting Basic Needs. The stock fell during the quarter as investor focus shifted away from defensive yield plays toward growth and cyclical sectors. Concerns about subscriber churn in a highly competitive wireless market, and the heavy capital expenditure requirements of continued network infrastructure investment, weighed on the share price."

#sustainable

Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
The stock market will be closed on Monday, Sept. 7, in observance of Labor Day. The market will reopen on Tuesday, Sept. 8.
In 2026, the stock market will observe 10 holidays, including two early closings. Many stock market holidays are also federal holidays and banking holidays.
The U.S. stock market's regular hours are 9:30 a.m. to 4 p.m. Eastern time, Monday through Friday. The two major U.S. stock exchanges, the New York Stock Exchange (NYSE) and the Nasdaq, each observe these trading hours. Both stock exchanges are closed on weekends.
You can still place orders to buy and sell stocks and exchange-traded funds (ETFs) during extended trading hours, but there is added risk. The trading volume is lighter after hours, so prices can be more volatile, and your orders may not execute fully.

#Stock #holidays

Sept 4 (Reuters) - Global money market funds attracted significant inflows in the week through September 2, as escalating U.S.-Iran tensions and a selloff ‌in global bonds prompted investors to increase cash holdings and favour shorter-duration ‌debt.
Investors added a net $46.1 billion to global money market funds, the biggest weekly inflow since August 5, according to LSEG Lipper data.
The United States struck Iranian military targets near the Strait of Hormuz, while Tehran said it had targeted U.S. **** ets across the region. Brent crude climbed to a nearly 1-1/2-month high of $97.62 a barrel, adding to inflation concerns.
Rate ‌worries also resurfaced after Federal ⁠Reserve Chair Kevin Warsh said last week that the central bank would "have work to do" if policymakers were not confident underlying ⁠inflation was returning to its 2% target.
Meanwhile, global equity funds attracted net inflows of $6.65 billion, more than reversing the previous week's $6.13 billion in outflows.

#billion #investors #attracted #inflation

On August 25, Electromed (NASDAQ:ELMD) reported fiscal fourth-quarter results that extended a streak few small-cap medical device companies can claim: fifteen consecutive quarters of year-over-year revenue and profit growth. Net revenue hit a record $19.4 million, up 11.6% from a year earlier, and diluted earnings per share climbed to $0.39 from $0.25. Those headline numbers look clean, but they arrive alongside a leadership change and a hospital business moving in the opposite direction, which makes the quarter more complicated than the growth streak suggests.
Home care is still the whole story here. Home care revenue reached $17.7 million in the quarter, up 15.2% year over year, and for the full fiscal year it grew 16.3% to $66.6 million. That growth is coming from efficiency, not just headcount: on an annualized basis, home care revenue worked out to $1,145,000 per rep, above the company's own target range of $1 million to $1.1 million. Electromed ended the year with 64 direct sales reps and is targeting 67 filled territories for fiscal 2027, including two hospital account liaisons meant to catch patients as they move from acute care into home-based therapy.
The addressable market behind that growth still looks large. Management estimates roughly 1 million people in the U.S. carry a bronchiectasis diagnosis, yet only about 16% currently use high-frequency chest wall oscillation therapy, leaving close to 800,000 diagnosed patients untreated, plus more than 4 million additional people who may have the condition without a diagnosis at all. Payer access has kept pace with that opportunity.
Electromed closed the fiscal year with 87% of US covered lives under contract after signing 40 new payer agreements and adding 6 million covered lives. Its Smart Order e-prescribing tool handled 45% of fourth-quarter orders and shipped them noticeably faster than fax submissions, which matters as CMS rules phase out fax-based ordering by May 2028. All of this sits on a debt-free balance sheet, with cash growing to $20.5 million even after $3.9 million in share repurchases during the year.
The weaker spots are easy to miss next to those numbers. Hospital revenue fell 29% in the fourth quarter, which CEO James Cunniff attributed to a sales cycle that is "inherently less predictable than our other channels." The distributor channel grew just 2% in the quarter, and combined, the non-home care business grew only 6.7% for the full year versus 16.3% in home care, meaning nearly all of Electromed's growth is coming from one channel. SG&A expenses rose 8.7% to $42.7 million for the year, driven mainly by higher sales, marketing, and reimbursement compensation, and accounts receivable climbed to $29.8 million from $24.7 million as the business scaled up.

#quarter #Growth #electromed #hospital

Dow Jones futures turned higher early Wednesday, while S&P 500 futures and Nasdaq futures fell but off lows as oil prices reversed lower. Dell Technologies, Palo Alto Networks, Credo Technology and MongoDB are notable overnight earnings movers.
The stock market rally came under further pressure with the Dow Jones and S&P 500 dropping below key levels. Crude oil prices jumped on fresh U.S.-Iran attacks while Treasury yields also moved higher.
Software had a tough session, with CrowdStrike (CRWD). Miners continued to slide, along with underlying metal prices, including Ero Copper (ERO)
Apple (AAPL) flashed a buy signal. So did Canadian Natural Resources (CNQ), Tidewater (TDW), CF Industries (CF) and Nutrien (NTR).
The video embedded in the article reviews Tuesday's market action and ******* yzes Apple stock, Canadian Natural Resources and Ero Copper. CF Industries is on Leaderboard. Canadian Natural Resources was Tuesday's IBD Stock Of The Day.

#copper #industries

Oil prices surged Tuesday following U.S. military action against Iranian targets in the Strait of Hormuz, a retaliatory move after Tehran launched overnight attacks on vessels passing through the waterway.
The November Brent crude contract jumped 3.8% to $94.36 a barrel, a level not seen in nearly two weeks. West Texas Intermediate, the U.S. benchmark, gained 4.3% to $89.46 a barrel for the October delivery contract, a move that would mark its best close in more than a month.
The afternoon rally built on momentum that had already been building since the morning session, with settlement data for both benchmarks sourced from Dow Jones Market Data.
The strikes mark a renewed escalation in the Strait of Hormuz, which has been the site of ongoing conflict. The U.S. and Iran had signed a memorandum of understanding on June 17, but that agreement collapsed almost immediately. Since then, Iran has demanded sanctions relief and an end to the U.S. naval blockade before the waterway can reopen, while Washington has maintained the blockade rather than conducting additional airstrikes — until Tuesday.
The Hormuz disruptions have taken a significant toll on global oil supply. The International Energy Agency cut its 2026 global oil supply forecast to 102 million barrels per day in August, a decline of 4.3 million barrels per day on the year, citing the breakdown of the ceasefire and a renewed closure of the strait. Middle East oil loadings had briefly touched 20 million barrels per day in early July before retreating to roughly 12 million barrels per day as attacks on tankers and energy infrastructure resumed. The IEA projected the global oil market would show a deficit of 1.8 million barrels per day in the third quarter of 2026.

#million #strait #global #market

Riverwater Partners, an investment management company, released its 'Small Cap Strategy' Q2 2026 investor letter. The letter can be downloaded here. The Small Cap Strategy underperformed the Russell 2000 in the second quarter as the benchmark experienced one of its strongest risk-on rallies in recent memory, although the strategy remained ahead year-to-date. The quarter was defined by accelerating AI investment, energy market disruptions, and renewed investor appetite for higher-beta stocks, creating headwinds for the firm's quality-focused approach and healthcare positioning. Despite this, stock selection contributed positively in energy, materials, and financials, while healthcare and consumer discretionary detracted due to the fund's disciplined avoidance of speculative businesses. Looking ahead, the firm remains cautiously optimistic, focusing on opportunities created by market dislocations, including AI infrastructure enablers, select consumer companies, healthcare innovators, and energy businesses trading below intrinsic value. The strategy continues to emphasize high-quality companies with strong management teams and attractive valuations, positioning the portfolio for a potential rotation away from speculative market leadership. In addition, please check the Strategy's top five holdings to know its best picks in 2026.
In its second-quarter 2026 investor letter, Riverwater Partners Small Cap Strategy highlighted NetScout Systems, Inc. (NASDAQ:NTCT) as a new addition. NetScout Systems, Inc. (NASDAQ:NTCT) provides carrier service ****** urance, cybersecurity, and Distributed Denial-of-Service (DDoS) solutions to protect digital business services against disruptions. On August 31, 2026, NetScout Systems, Inc. (NASDAQ:NTCT) closed at $38.83 per share. The one-month return of NetScout Systems, Inc. (NASDAQ:NTCT) was -8.01% and its shares gained 57.59% over the past 52 weeks. NetScout Systems, Inc. (NASDAQ:NTCT) has a market capitalization of $2.82 billion with a 52-week trading range between $24.27 - $45.28.
Riverwater Partners Small Cap Strategy stated the following regarding NetScout Systems, Inc. (NASDAQ:NTCT) in its Q2 2026 investor letter:
"We initiated a position in NetScout Systems, Inc. (NASDAQ:NTCT) in April. Founded in 1984, NetScout Systems, Inc. (NTCT), with a stated mission of "Guardians of A Connected World," has been a technology innovator providing service ****** urance and cybersecurity solutions based on its pioneering deep packet inspection technology at scale. While high-growth competitors trade at significant premiums, NetScout offers a more attractive valuation for what we view as a durable software business with deeply embedded customer relationships among the Fortune 500. Its deep packet inspection technology is increasingly critical as enterprises navigate complex digital transformations, cloud migrations, and a heightened threat landscape. We view NTCT as a disciplined way to gain exposure to secular technology tail

Tesla
TSLA
-3.22%
stock rose Monday with investors waiting for more self-driving updates. The company continues to work on its
autonomous driving technology
. Pothole avoidance is coming soon, according to
Elon Musk
.
TSLA
-3.22%
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

#Monday

With a market cap of $209.7 billion, Salesforce, Inc. (CRM) is a leading customer relationship management (CRM) technology company that helps businesses connect with customers across the United States, Europe, and the Asia Pacific. It serves a wide range of industries including financial services, healthcare, manufacturing, automotive, and government sectors.
Companies valued at $200 billion or more are generally classified as "mega-cap" stocks, and Salesforce fits this criterion perfectly. The company provides AI-powered solutions such as Agentforce, Data 360, Informatica, and Slack, enabling organizations to automate processes, manage data, and improve collaboration across sales, service, marketing, and commerce operations.
Wu-Tang Clan Member Raekwon Is a Palantir 'OG,' Visiting Headquarters 16 Years After Receiving His Custom PLTR Jacket
Tesla Stock Could Benefit as Trump Locks Down the U.S. Power Grid
Tesla Just Killed Its Solar Roof After Years of Struggling to Scale. What It Means for TSLA Stock.

#Stock

Over the past 100 years, a simple buy-and-hold investment in the S&P 500 (SNPINDEX: ^GSPC) would have been one of the best ways to make money. During that time, the index averaged a roughly 10% annual return.
At that return, a $100 investment in the S&P 500 100 years ago would have turned into nearly $1.4 million.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
While returns can vary widely on a short-term basis, it's still reasonable to think that a 10% average annual return for index funds such as the Vanguard S&P 500 ETF (NYSEMKT: VOO) is possible over the next 20 years.
If that were to happen without any additional contributions at all, a $10,000 investment would grow to roughly $67,275 or a total return of more than 570%.

#time

Qiagen N.V. (NYSE:QGEN) announced on August 10 that the U.S. FDA cleared its QIAstat-Dx BCID GPF Plus AMR Panel, marking the company's first entry into the U.S. bloodstream infection testing market. Operating on the QIAstat-Dx platform, which boasts over 5,200 global placements, the automated panel detects 20 gram-positive bacterial and fungal targets, alongside 10 genetic antimicrobial resistance markers, in about one hour.
This regulatory milestone comes shortly after Qiagen N.V. (NYSE:QGEN) reported solid Q2 2026 financial results on August 5. Net sales reached $535 million (flat YoY at constant exchange rates), beating guidance for a 2% decline. Adjusted diluted EPS rose 3% YoY to $0.62, topping expectations. Performance across core growth pillars (+5% CER), including Sample Technologies (+9% CER) and QIAcuity digital PCR, helped offset a 7% drop in QIAstat-Dx respiratory testing sales. QGEN reaffirmed its full-year 2026 outlook for 1%–2% CER net sales growth and adjusted EPS of at least $2.43.
Additionally, Qiagen announced that Jonathan Pratt will take over as CEO effective September 1, succeeding Thierry Bernard. Joining at a pivotal time, Pratt will lead executive execution following an intensive portfolio evaluation and ongoing corporate efficiency programs.
This brings up a key question: Does the FDA clearance and steady execution under incoming leadership position Qiagen N.V. (NYSE:QGEN) for a valuation rerating, or will soft regional demand and product mix headwinds keep shares range-bound?
Bulls argue that Qiagen's high-margin, consumable-driven business model (comprising 90% of total Q2 sales) provides defensive recurring cash flow, generating $301 million in H1 operating cash flow. The new FDA approval expands QIAstat-Dx into its fourth major infectious disease area in the U.S., unlocking higher-margin hospital diagnostic channels. Furthermore, solid growth across core pillars like Sample Technologies and QIAcuity demonstrates fundamental demand. Strong internal cash generation also gives incoming CEO Jonathan Pratt ample balance sheet capacity to pursue disciplined capital deployment and portfolio innovation.

#qiagen

On August 13, Celcuity (NASDAQ:CELC) walked investors through a quarter unlike any in the company's history. The clinical-stage biotech is no longer just clinical: its breast cancer drug Revtopik won FDA approval on July 14, and the call was built around how the company plans to turn that approval into an actual business. The tone was confident, but the numbers underneath told a more complicated story about what launching a first drug really costs.
The regulatory news alone stood out. The FDA approved Revtopik on July 14 for patients with HR positive, HER2-negative advanced breast cancer without a PIK3CA mutation who had progressed on prior endocrine therapy. Less than three weeks later, the National Comprehensive Cancer Network recommended both the Revtopik triplet and doublet as preferred Category 1 options for second-line treatment, a fast endorsement suggesting oncologists see real value here.
That value shows up in the data. In the PIK3CA mutant cohort of the VIKTORIA-1 trial, the gedatolisib triplet produced a median progression-free survival of 11.1 months versus 5.6 months for alpelisib plus fulvestrant, cutting the risk of progression or death in half. Just 5.2% of triplet patients and 3.8% of doublet patients stopped treatment due to side effects, compared to 19% on alpelisib. CEO Sullivan said that 4% to 5% range "best represents what we expect to see in a real world setting," a detail that matters because patients who stay on a drug longer generate more revenue over time.
Celcuity is not stopping at second-line treatment either. The VIKTORIA-2 trial has been expanded to test gedatolisib in treatment-naive, endocrine-sensitive patients, a group that makes up roughly two-thirds of newly diagnosed advanced breast cancer cases each year. That bet is backed by earlier Phase 1b data showing a median progression-free survival of 48.6 months, nearly double the roughly 25 months typical of current standard of care. Commercially, the company says its 80-person oncology sales team, averaging 24 years of experience, is fully built, backed by $754 million in cash management expects to last into 2029.
Turning that approval into revenue has been expensive. Net loss widened to $78.9 million, or $1.44 per share, for the quarter, compared to a loss of $45.3 million a year earlier. Selling, general, and administrative expenses jumped $27.4 million to $35 million, driven mostly by hiring the commercial team needed to support the launch. Celcuity has not shipped a single vial yet, with shipments not expected to begin until late in the third quarter of 2026.

#cancer #months #quarter

Clothing chain The Gap (NYSE: GAP) stock soared 13% through 11:35 a.m. ET Friday after exceeding **** yst targets for earnings last night.
Heading into its Q2 report, Wall Street had Gap pegged for a $0.49 per share profit on sales of $3.7 billion. Gap met the sales forecast and beat on earnings, reporting pro forma profit of $0.52 per share.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Image source: Getty Images.
Not all Gap's news was good. While sales met expectations, they declined 2% year over year, including a 1% decline in same-store sales. Despite investors' positive reception, CEO Richard **** son called these results "modestly below expectations."

#expectations

SAP (NYSE:SAP) faces a slower path to monetizing artificial intelligence, according to UBS, which downgraded the German software giant to Neutral from Buy on concerns that agentic AI is reaching customers too slowly.
The Swiss bank said SAP remains a dominant system of record with a deep moat around its core enterprise resource planning business, but the pace of "out-of-the-box" AI agent delivery is lagging. SAP has rolled out just 17 such agents to date, with another 15 in ramp-up, leaving its target of 200 by year-end looking difficult to reach, UBS **** ysts wrote.
The complexity of SAP's largest customers, many running multiple ERP instances across different versions and often on private cloud deployments with custom coding, complicates the company's ability to deliver standardized AI tools, according to the note. UBS said it is hearing positive signals on customers building their own agents through Joule Studio, but adoption remains gradual, making it hard to disprove bearish views on SAP's AI relevance in the near term.
UBS expects cloud backlog growth to decelerate in the second half of the year toward management's guided ~23% constant-currency pace, down from Q2's 26% (24.6% organic), a slowdown likely to pressure shares without clearer AI traction.
UBS also cited falling cloud gross, higher AI token costs pressuring R&D spending, a 100 million euro cut to 2026 EBIT guidance from acquisition dilution, and management's warnings about IT spending risks tied to the Gulf conflict.

#remains #german

Citizens' **** yst Andrew Boone recently reiterated a Market Outperform rating on Amazon.com, Inc. (NASDAQ:AMZN) with a $315 price target. The firm noted that Amazon trades at 23.8x 2027E GAAP EPS and 10.9x 2027E EBITDA. However, it believes that the stock deserves to trade at a higher valuation.
Citizens believes that two factors support a higher valuation for Amazon.com, Inc. (NASDAQ:AMZN), one of which is its cloud computing leadership through Amazon Web Services. AWS is currently the undisputed leader in cloud infrastructure with an estimated 28% of market share.
In the second quarter of 2026, AWS net sales grew 37% year-over-year to $42.2 billion. Operating income for the segment grew to $16.6 billion from $10.2 billion a year ago. This means that AWS accounted for an estimated 60% of Amazon's operating income while contributing one-fifth of revenue.
AWS is now essentially a "$169 billion annualized revenue run rate business," with the company now building a narrative around their custom silicon. The business has a chips revenue run rate "over $25 billion," and an AI-specific revenue run rate also "over $25 billion."
On the retail side, North America segment sales rose 16% to $$116.2 billion. Operating income climbed to $9.1 billion, supported by the company's efficient fulfillment network.

#revenue #year #rate #NASDAQ

A $40 trillion debt load and surging AI capital demand have pushed the 30-year Treasury yield above 5.3% for the first time since 2007.
Bessent's $950 billion TGA headline masks a usable buffer of only $100 to $200 billion, making his bond market tools far smaller than advertised.
Citadel Securities labels Bessent's yield suppression 'financial repression,' warning that political optics could drive bond vigilantes to demand even higher yields.
Don't wait: the ******* yst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Long-term Treasury yields are telling a different story from short-term interest rates. The 10-year yield has pushed toward 5%, while the 30-year recently climbed above 5.3% for the first time since 2007. The problem is bigger than the Federal Reserve.

#year #yield #above

By David Lawder and Dan Burns
WASHINGTON, Aug 24 (Reuters) - The U.S. Treasury will continue with its regularly scheduled debt auctions, including for long-dated bonds, despite its move to increase buyback sizes of 10- to 30-year securities, Treasury Secretary Scott Bessent said on Monday.
Asked at a news ‌conference focused on Iran sanctions about Treasury's plans for bond buybacks and auction sizes going forward, Bessent said the department would "continue with our regular ‌program of auctions" announced in early August.
He added that the Treasury hasn't purchased any bonds yet in the enlarged buybacks, which will start on September 10 for 10- and 20-year securities.
Bessent, a former hedge fund manager with extensive experience in sovereign debt and currency markets, last week surprised global bond investors by announcing the Treasury would double the size of its quarterly repurchases of longer-dated bonds after their yields reached the highest levels in nearly two decades.

#auctions

Almir Ambeskovic, CEO of TheFork, reported the disposition of 5,200 shares of Tripadvisor, Inc. (NASDAQ:TRIP) on Aug. 14, 2026, according to a recent SEC Form 4 filing.
Metric
Value
Transaction value
$53,612

#transaction

AstraZeneca PLC (NYSE:AZN) is paying $600 million upfront to secure global rights to Zegfrovy from Dizal Pharmaceutical Co., Ltd, adding another targeted therapy to one of the pharmaceutical industry's largest oncology portfolios. Dizal Pharmaceutical could receive an additional $900 million if specified development, regulatory, and sales milestones are achieved, bringing the agreement's potential value to $1.5 billion. Dizal will also receive tiered royalties on the global sales of Zegfrovy.
Zegfrovy, also known as sunvozertinib, is an oral treatment approved in the United States and China for certain adults with locally advanced or metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations, whose disease has progressed on or after platinum-based chemotherapy. Under the agreement, AstraZeneca (NYSE:AZN) will take responsibility for the treatment's global development and commercialisation.
For AstraZeneca (NYSE:AZN) shareholders, the transaction offers an opportunity to ****** s whether another targeted lung-cancer medicine can reinforce the company's oncology leadership, or whether the price adds further execution risk to an already extensive pipeline.
The agreement strengthens AstraZeneca's (NYSE:AZN) position in a therapeutic area where it already has substantial scientific and commercial experience. The company has built a major lung-cancer business around treatments including Tagrisso, Imfinzi, and Enhertu. That existing infrastructure could help AstraZeneca (NYSE:AZN) introduce Zegfrovy to physicians and patients more efficiently than a smaller developer with a limited global presence.
Zegfrovy also addresses a specific group of patients with EGFR exon 20 insertion mutations, for whom treatment options remain limited. In the Phase III WU-KONG28 trial, Zegfrovy produced median progression-free survival of 10.3 months, compared with 7.5 months for chemotherapy. AstraZeneca (NYSE:AZN) therefore gains an approved medicine supported by late-stage comparative evidence rather than an early experimental ****** et whose clinical viability remains largely unknown.

#lung #egfr

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below.
Warren Buffett has spent more than eight decades outperforming Wall Street. Yet, ordinary Americans can follow a much simpler strategy to build wealth.
"America has been a wonderful place to invest money," Buffett told CNBC's Becky Quick in an interview (1).
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
JPMorgan sees gold hitting $5,000/oz by Q4 — and savvy investors are protecting their wealth with a tax-advantaged Gold IRA. Get your free guide from Priority Gold

#Invest

Way back in 1996, when I was a cub reporter for The Wall Street Journal, then-Federal Reserve Chairman Alan Greenspan made a speech in Washington that rocked the financial world.
"But how do we know when irrational exuberance has unduly escalated **** et values, which then become subject to unexpected and prolonged contractions," Greenspan famously said.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Investors around the world listened and then sold on the warning. However, the sell-off was brief, and the dot-com bubble continued to inflate for three more years before crashing in early 2000, wiping 78% from the Nasdaq Composite and 49% from the S&P 500 by October 2002.
What might Greenspan, if he were still alive, say about the current stock market?

#NVIDIA #flashing

McDonald's (MCD) just entered the energy-drink market, but the bigger question for investors is whether the move can help revive the stock after a difficult year. The company began selling its Red Bull Dragonberry Energizer across U.S. restaurants on Aug. 17, marking McDonald's first entry into energy drinks.
The timing is interesting because McDonald's recently delivered a mixed second-quarter report. Adjusted earnings came in at $3.38 per share, beating the $3.32 consensus estimate, while revenue of roughly $7.1 billion fell slightly short of the $7.14 billion estimate.
Third Point Starts to Raise Alarm Bells on Broadcom After Dumping AVGO Stock in Q2
Nvidia Q2 Preview: Strong Earnings and Low Valuation Set the Stage for Upside
A $28.7 Billion Reason to Buy SK hynix Stock Now

#billion #energy

Jenna O'Malley/PitchBook News
Talk of AI adoption is pervasive in PE, but would you trust the technology enough to let it manage your own firm? Ethos Capital is testing these limits.
The Boston-based PE firm spent around five years building Private Equity Transformation Research Agent—or Petra—an AI ******* istant trained on more than 50,000 data sources, including decks outlining every deal the firm has taken or passed on, as well as public information ranging from regulatory filings to news and video.
Today, Petra is woven into nearly every aspect of Ethos' business, from filtering pitch decks, running initial diligence, monitoring portfolio companies to managing investor relationships. Ethos even uses AI to track its own employees' work, according to Fadi Chehadé, co-founder and managing partner at the $7 billion investment firm.
Launched by Chehadé and Erik Brooks, two Abry Partners alumni, in 2019, Ethos targets middle-market companies with an enterprise value of $200 million to $2 billion, focusing on supply chain and logistics, insurance and financial services and digital platforms.

#ethos #decks #every #Managing

Global data center energy usage is expected to rise 26% by 2026 to 565 terawatt-hours, while overall data center power demand will soar by 27% to 132 gigawatts. As grid capacity limits become the most significant bottleneck for hyperscalers, standby and prime continuous power generation systems have evolved into mission-critical equipment. For industrial **** ans Caterpillar Inc. (NYSE:CAT) and **** mins Inc. (NYSE:CMI), the steady demand for distributed power, along with strong North American construction expenditures, is driving record backlogs and prompting full-year guidance increases across the board.
The convergence of infrastructure investment and AI power demand was clearly visible when Caterpillar Inc. (NYSE:CAT) released its second-quarter 2026 results on August 4. Total sales increased 24% year-over-year to $20.5 billion, while adjusted earnings per share hit $8.17, greatly exceeding the $6.20 **** yst average expectation and igniting a 9% premarket stock rise. Operating margins increased to 20.9% from 17.3% the previous year, indicating a significant improvement in efficiency. Construction Industries led the way, growing 35% to $8.3 billion on a 50% increase in North American demand, while Power & Energy increased 17% to $8.2 billion.
Trade difficulties also eased during the quarter. After incurring a $710 million negative manufacturing cost hit largely from tariffs in Q1, Caterpillar Inc. (NYSE:CAT) reduced its full-year tariff forecast to approximately $2.2 billion (down from $2.2-$2.6 billion) and won $392 million in tariff recoveries under the International Emergency Economic Powers Act (IEEPA). Cash generation was also strong, with operating cash flow of $4.4 billion. Management increased full-year revenue expectations to mid- to high-teens percentage growth (up from low-double-digits), while returning $2.2 billion to shareholders in Q2 alone, including $1.5 billion in share buybacks and $0.7 billion in cash dividends.
In the same vein, **** mins Inc. (NYSE:CMI) told a very similar story of power-driven demand. The company reported record revenue of $9.5 billion, GAAP net income of $932 million, an EBITDA margin of 17.5%, and diluted earnings per share of $6.73. Synchronized demand from North American on-highway transport, Chinese construction activity, and high-performance generator sets for commercial data centers all helped operations.
Cummins Inc. (NYSE:CMI) increased its full-year revenue guide for 2026 to 10-13% growth (up from 8-11%) and its full-year EBITDA margin forecast to 18.0-18.5% (up from 17.75-18.5%). The company also maintained a disciplined capital deployment strategy, returning $501 million to shareholders in the quarter through dividends and buybacks.

#caterpillar

Pershing Square Holdings, an investment holding company, released its second quarter 2026 investor letter. A copy of the letter can be downloaded here. Pershing Square is an alternative **** et manager that primarily manages capital in publicly traded investment vehicles, with 98% of its capital structure dedicated to such **** ets, including Howard Hughes Holdings. This capital permanency allows for long-term investments, fostering sustainable competitive advantages and yielding substantial market returns since 2018. The investment strategy focuses on acquiring high-quality companies at safe price points, anticipating significant annual EPS growth of 15% or more in the coming years. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Pershing Square Holdings Howard Hughes Holdings Inc. (NYSE:HHH). Headquartered in The Woodlands, Texas, Howard Hughes Holdings Inc. (NYSE:HHH) develops and manages master planned communities. On August 18, 2026, Howard Hughes Holdings Inc. (NYSE:HHH) closed at $65.76 per share. The one-month return of Howard Hughes Holdings Inc. (NYSE:HHH) was 1.07% and its shares lost 10.68% over the past 52 weeks. Howard Hughes Holdings Inc. (NYSE:HHH) has a market capitalization of $3.93 billion.
Pershing Square Holdings stated the following regarding Howard Hughes Holdings Inc. (NYSE:HHH) in its Q2 2026 investor letter:
"At Howard Hughes Holdings Inc. (NYSE:HHH) in June, we closed the acquisition of Vantage Group Holdings Ltd. ("Vantage"), a specialty insurance and reinsurance company. We thereafter announced a leadership transition whereby former Arch Capital Group (NASDAQ: ACGL) CEO Marc Grandisson became Executive Chairman of Vantage, and David Gansberg, Marc's former co-President, will become CEO of Vantage when his non-compete ends in June of next year. Marc and David recently worked as close partners to grow Arch, one of the most successful insurance and reinsurance companies. During Marc's nearly seven-year tenure as CEO, Arch delivered a total shareholder return of 298%, or 23.2% per annum, compared to 144% and 14.4% for the S&P Insurance Index over the same period.
With the benefit of Marc's and David's leadership and Pershing Square's fee-free management of Vantage's investment portfolio, we believe that HHH is well-positioned to become what we have deemed a modern-day Berkshire Hathaway. While HHH generates a small portion of Pershing Square's fee revenues today, we believe that HHH now has the potential to accelerate its growth in intrinsic value and share price, which will drive HHH's market capitalization and, in turn, the variable service fees that we will earn from the company..." (Click here to read the full text)

#howard #vantage #capital

On August 17, AECOM (NYSE:ACM) delivered a third quarter that looked strong and messy at the same time. Backlog hit an all-time high on record quarterly wins, yet the company also absorbed a $337 million pretax charge tied to a delayed construction project. The result was a quarter where headline numbers cratered even as the underlying business kept expanding. That gap between top-line noise and forward momentum is what makes this print worth a closer look.
AECOM's backlog grew 13% to a new all-time high, powered by record quarterly wins and a company-wide book-to-burn ratio of 1.6, including 1.8 times in the Americas. Year to date, that ratio sits at 1.4, giving management unusually long visibility into future revenue. The design business, adjusted for one fewer working day, grew net service revenue 5%, with the Americas up 6% and international design returning to growth at 4%, led by the UK and Australia. Stripped of the charge, adjusted EBITDA climbed 5% and adjusted earnings per share rose 11% year over year, while the company raised its full-year adjusted EBITDA margin outlook to 17.4% from 17%.
Wins are coming from every direction. Canada landed a 10-year program management role on a highway and bus transit project, one of the company's largest Canadian awards ever, while Australia's backlog jumped more than 40% year over year. In the U.K., work on the Great Grid electricity upgrade helped push growth into the high single digits. The federal pipeline is expanding too, with the pipeline tied to the Department of War up roughly 30% in the quarter and less than half of IIJA infrastructure funding in AECOM's core markets spent so far. The balance sheet backs it up, with $2 billion of undrawn borrowing capacity and no near-term debt maturities.
The $337 million pretax charge stems from a construction management project first bid in 2019, where subcontractor productivity has pushed substantial completion from the first quarter of fiscal 2027 to near the end of the second quarter. That slippage cost $1.99 of earnings per share this quarter and forced a $185 million cash use, and management expects the project to keep burning cash through the first half of fiscal 2027. A second design-build P3 project from the same era also carries a significant claim position as AECOM pursues recoveries, even though the company says it no longer bids that structure for public-private partnership clients.

#year